Rachel Dickie, Director of Urban Regeneration at Legal & General Capital joins Chris Walters, Investor & Developer Life Sciences Lead at JLL to discuss the future of the life sciences industry from their perspective as a funder, investor and developer. During this podcast Rachel explains why L&G’s purpose as a company has resulted in its commitment to the sector, promoting sustainable growth that benefits society and supports economic growth across the UK. Rachel also dives into the intrinsic link between regeneration and life sciences, which she believes will grow from strength to strength in the coming years.

Dr Glenn Crocker, Head of Life Sciences at JLL joins Chris Walters, Investor & Developer Life Sciences Lead to introduce Clustering Insights (our new podcast series) and discuss the impact and response to COVID-19 for investors and operators.

Will the UK life sciences market ever catch up to the US? In this episode we are joined by Douglass Cuff, Vice President of UK Real Estate at IQHQ. We dive into the key drivers that propelled the US market and the opportunities within the UK. He joins Chris Walters to discuss these differences, as well as the ongoing impact COVID-19 is having on the short term and long term prospects for the life sciences industry.

Matthew Jones, Partner at Hoare Lea joins Chris Walters, Investor & Developer Life Sciences Lead in this episode to debunk the myths within the life sciences sector. Matthew takes us through what is influencing design and engineering and the impact that the emerging innovation culture is having on the market.

Pete Wilder, Head of Property at Oxford Sciences Innovation (OSI) joins Chris Walters, Investor & Developer Life Sciences Lead in this episode to provide us with an inside view on the future of the Life Sciences market and its physical real estate needs.